Patent ID: 9512427
Filing Date: 2016-12-06
CPC Classification: A61K,A61P,C12N,Y02A

Claim Text:
1. A method of upregulating a function of and/or the expression of an Antiviral gene polynucleotide in patient cells or tissues in vivo or in vitro comprising: contacting said cells or tissues with at least one antisense oligonucleotide of 12 to 30 nucleotides in length that targets and specifically hybridizes to a complementary 12 to 30 nucleotide region of a natural antisense polynucleotide of the Antiviral gene polynucleotide selected from a IF1H1 (MDA5) gene having SEQ ID NO: 2 wherein said natural antisense polynucleotide comprises SEQ ID NOS: 7 or 8; thereby upregulating a function of and/or the expression of the Antiviral gene polynucleotide in patient cells or tissues in vivo or in vitro.